Sponsor:
Candel Therapeutics, Inc.
Code:
NCT07332000
Conditions
Prostate Cancer Patients Treated by Radiotherapy
Prostate Cancer (Adenocarcinoma)
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
aglatimagene besadenovec + valacyclovir
External Beam Radiation Therapy (EBRT)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Candel Therapeutics, Inc. on 2026-02-19.